Jennifer Sheng

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Placebo Controlled

Top Venues

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yoon-Koo Kang, Martin Reck, Paul T Nghiem, Yan Feng, Gregory Plautz, Hye Ryun Kim, Taofeek Kunle Owonikoko, Narikazu Boku, Li-Tzong Chen, Ming Lei, Han Chang, Wen Hong Lin, Amit Roy, Akintunde Bello, Jennifer Sheng
Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials. Journal for immunotherapy of cancer 10 (4) (2022)